Results

291 - 300 of 321 results for ‘guidelines’.

  • 21. Rubella

    http://tewhatuora.govt.nz/for-health-professionals/clinical-guidance/immunisation-handbook/21-rubella

    ... the chance of being exposed in New Zealand to an infectious case is becoming increasingly rare, rubella remains endemic in some countries, and the risk remains to those who are unimmunised when travelling overseas or through an imported case. (If exposure during pregnancy does occur, see the guidelines in   section 21.8.2 .) After delivery If MMR and Rhesus anti-D IG are required after delivery, both the vaccine and anti-D IG may be given at the same time, in separate sites with separate syringes. The vaccine may be given at any time after the delivery. Anti-D IG does not interfere with ...

  • Arboviral diseases

    http://corporat-prod.sites.silverstripe.com/for-health-professionals/clinical-guidance/communicable-disease-control-manual/arboviral-diseases

    ... CDC. 2004. West Nile Virus (WNV). Information and guidance for clinicians. Department of Health and Human Services, Centers for Disease Control and Prevention. United States Department of Health and Human Services. Communicable Diseases Prevention and Control Unit. 2008. The Blue Book: Guidelines for the control of infectious diseases. Victoria: Public Health Branch, Department of Human Services, State Government of Victoria. Department of Health and Ageing. 2004.   Australian National Notifiable Diseases Case Definitions (external link) . Canberra: Australian Government. Departme ...

  • Syphilis (Limited chapter)

    http://corporat-prod.sites.silverstripe.com/for-health-professionals/clinical-guidance/communicable-disease-control-manual/syphilis-limited-chapter

    ... may occur for at least 4 years after infection. Transmission through blood transfusions can occur if the donor is in the early stages of disease. For information on case management and contact tracing and management, refer to the  New Zealand Sexual Health Society syphilis management guidelines (external link) . Case definition – infectious syphilis Expand all Description Description Infectious syphilis is notifiable in Aotearoa New Zealand. This includes syphilis of less than 2 years’ duration (primary, secondary and early latent) and syphilis of unknown duration. Late latent sy ...

  • 6. Diphtheria

    http://tewhatuora.govt.nz/for-health-professionals/clinical-guidance/immunisation-handbook/6-diphtheria

    ... or chemotherapy pre- or post-splenectomy pre- or post-solid organ transplant undergoing renal dialysis prior to planned or following other severely immunosuppressive regimens. 6.6. Contraindications and precautions See also   section 2.1.3   for pre-vaccination screening guidelines and   section 2.1.4   for general contraindications for all vaccines. Expand all 6.6.1. Contraindications 6.6.1. Contraindications There are no specific contraindications to diphtheria vaccine (as Tdap or DTaP), except for anaphylaxis to a previous dose or any component of the ...

  • Measles

    http://tewhatuora.govt.nz/for-health-professionals/clinical-guidance/communicable-disease-control-manual/measles

    ... to the MMR vaccine, it may be difficult to distinguish from true measles infection. Standard polymerase chain reaction (PCR) testing cannot distinguish between vaccine and wild-type measles, therefore vaccine-strain-specific genotyping is required for diagnosis (refer to Laboratory testing guidelines ). Vaccine-associated measles Rarely, measles infection may develop in pregnancy or in immunocompromised people following vaccination with MMR (known as ‘vaccine-strain measles’ or ‘vaccine-associated measles’)  [24] . The clinical presentation can be indistinguishable from wild-t ...

  • Clinical trials and research units — Waikato

    http://corporat-prod.sites.silverstripe.com/for-health-professionals/health-research/district-and-regional-health-research/waikato/clinical-trials-and-research-units

    ... medicine Australasia : EMA, 10.1111/1742-6723.14029. Advance online publication.   https://doi.org/10.1111/1742-6723.14029 (external link) Karcher, C., Jurisevic, C., Southwood, T., McCormack, D., Rogers, A., Levine, A., & Dunning, J. (2023). The Australasian ANZSCTS/ANZICS guidelines on cardiothoracic advanced life support (CALS-ANZ). Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine, 24(3), 218–223.   https://doi.org/10.51893/2022.3.SA3 (external link) Lloyd, J., Gilliat, N., Porter, G., & Pirone, F. (2023). A case ...

  • Clinical Trials Unit

    http://corporat-prod.sites.silverstripe.com/for-health-professionals/health-research/district-and-regional-health-research/wellington-hutt-and-kapiti/clinical-trials-unit

    ... or longer, your meals will be provided. We can cater for special dietary requirements. Each bed for patients staying overnight has a dedicated television. General information about clinical trials General information about clinical trials Ethics approval is required for all trials, and guidelines exist that set out the established ethical standards that all researchers must meet when undertaking health and disability research in New Zealand. Read more about this on the Health and Disability Ethics Committees website. Health and Disability Ethics Committees (external link) For more clin ...

  • ISO/TC 215 Health informatics national mirror committee

    http://corporat-prod.sites.silverstripe.com/health-services-and-programmes/digital-health/data-and-digital-standards/isotc-215-health-informatics-national-mirror-committee

    ... Clinical Leadership Group Health Information Governance Expert Advisory Group Health Informatics New Zealand (HiNZ) She has more than 100 publications including the HISO standards HISO 10029:2009 Health Information Security Framework and HISO 10064:2017 Health information Governance Guidelines. Dr Derek Buchanan Dr Derek Buchanan Derek is a medical doctor and digital specialist who has more than 15 years of experience in the health sector. He has a strong interest in various standards and has been part of international working groups including HL7, SNOMED CT and BPM+ Health. He hold ...

  • Achieving equitable outcomes in communicable disease management

    http://tewhatuora.govt.nz/for-health-professionals/clinical-guidance/communicable-disease-control-manual/equity

    ... disease management, refer to Equity in Action section below. Equity in action Expand all Overview Overview This section provides practical examples of how to achieve equitable outcomes in communicable disease management, based on the 6 principles of the National Public Health Service (NPHS) guidelines for achieving equitable outcomes. Figure 2 provides a printable visual of the actions described below. The following actions are designed for both public health kaimahi and public health services. These examples are not exhaustive but provide tangible guidance as we work towards Pae Ora. Enlar ...

  • Dioxins questions and answers

    http://corporat-prod.sites.silverstripe.com/health-services-and-programmes/environmental-health/hazardous-substances/persistent-organic-pollutants-pops/dioxins/dioxins-questions-and-answers

    ... skin condition known as chloracne and cancer in some people. The adverse health effects associated with TCDD exposure are not fully known. Animal studies show immune, reproductive and developmental effects. These animal studies have been used internationally to establish health-based guidelines for exposure to dioxins in soil, air and food. The first evidence that dioxin may cause cancer was an animal study published in 1978 but it was not till 1997 that dioxin was classified as a human carcinogen (cancer causing agent) by the International Agency for Research on Cancer (IARC). In an ...